[Full text] Antibody-drug conjugates: targeted weapons sorted by
relevance

Admin01.10.2021

[Full text] Antibody-drug conjugates: targeted weapons

8704
Admin23.08.2021

[Full text] Antibody-drug conjugates: targeted weapons

3506
Admin02.09.2021

Mechanism of action of ADCs. The antibody-drug conjugate

8004
Admin01.08.2021

Molecules | Free Full-Text | Antibody-Drug Conjugates for

6309
Admin30.07.2021

Biomedicines | Free Full-Text | Antibody-Drug Conjugates

8704
Admin26.08.2021

[Full text] Antibody-drug conjugates: targeted weapons

8306
Admin26.08.2021

Pharmaceuticals | Free Full-Text | Antibody-Drug

Admin01.08.2021

Pharmaceuticals | Free Full-Text | Antibody-Drug

5401
Admin01.09.2021

Molecules | Free Full-Text | Antibody-Drug Conjugates and

9208
Admin22.07.2021

Antibodies | Free Full-Text | Antibody Drug Conjugates as

4200
Admin03.08.2021

Biomedicines | Free Full-Text | Antibody-Drug Conjugates

3901
Admin17.09.2021

Schematic illustration of antibody-drug conjugate (ADC

9305
Admin29.09.2021

DLL3: an emerging target in small cell lung cancer

9305
Admin26.08.2021

[Full text] Antibody-drug conjugates: targeted weapons

309
Admin04.10.2021

Biomedicines | Free Full-Text | Antibody-Drug Conjugates

7700
Admin23.07.2021

General structure of antibody drug conjugates (ADC) and

2700
Admin04.10.2021

Working model of α-amanitin antibody-drug conjugates

Admin29.09.2021

Cancers | Free Full-Text | Tumor-Targeted Drug Conjugates

4807
Admin28.08.2021

Cancers | Free Full-Text | Antibody-Drug Conjugates: A

8007
Admin12.09.2021

Antibodies | Free Full-Text | Antibody Drug Conjugates as

42010
Admin15.08.2021

All approved antibody-drug conjugates (ADCs) by CDER of

2601